GeneTex

  • Country / Location Selection

United States (US)

SNRPN blocking peptide

Cat. No. GTX31617-PEP

Application

 Neutralizing/Inhibition
Package
50 μg ($139)
See all SNRPN products
PRODUCT

Summary

SNRPN peptide is used for blocking the activity of SNRPN antibody (catalog number GTX31617).

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Recommended Dilution
Neutralizing/Inhibition Assay dependent
Not tested in other applications.

PROPERTIES

Form

Liquid

Buffer

PBS, 0.1% BSA

Preservative

0.02% Sodium azide

Storage

Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.

Concentration

200 μg/ml (Please refer to the vial label for the specific concentration.)

Conjugation

Unconjugated

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Small Nuclear Ribonucleoprotein Polypeptide N , Hcern3 , Pwcr , Rt-Li , Sm-D , Smn , Snrnp-N , Snurf-Snrpn , Sm-N , Snrpn

Background

The protein encoded by this gene is one polypeptide of a small nuclear ribonucleoprotein complex and belongs to the snRNP SMB/SMN family. The protein plays a role in pre-mRNA processing, possibly tissue-specific alternative splicing events. Although individual snRNPs are believed to recognize specific nucleic acid sequences through RNA-RNA base pairing, the specific role of this family member is unknown. The protein arises from a bicistronic transcript that also encodes a protein identified as the SNRPN upstream reading frame (SNURF). Multiple transcription initiation sites have been identified and extensive alternative splicing occurs in the 5' untranslated region. Additional splice variants have been described but sequences for the complete transcripts have not been determined. The 5' UTR of this gene has been identified as an imprinting center. Alternative splicing or deletion caused by a translocation event in this paternally-expressed region is responsible for Angelman syndrome or

REFERENCE

There are currently no references for SNRPN blocking peptide (GTX31617-PEP). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for SNRPN blocking peptide (GTX31617-PEP). Be the first to share your experience with this product.
Submit a Review
SDS
PBS.pdf
Sodium Azide.pdf
Package List Price ($)
$ 139